Every one of those 1 sits in a single category, legal-tech. NEOVAULT is most often covered alongside DRUID, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.7 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about NEOVAULT
Every one of those 1 sits in a single category, legal-tech. NEOVAULT is most often covered alongside DRUID, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.7 for the broader beat in this window. At 6, the average consequence score sits below the same-window beat average of 6.3. NEOVAULT appears in 1 tracked Legal story from February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 50 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering NEOVAULT. Shared-story counts are live from our verified record — not editorial picks.
HSI Donesafe and Neopharma Technologies have launched a strategic API integration to embed Fit-For-Duty workflows directly into safety management systems. The partnership centralizes drug, alcohol, and cognitive impairment assessments, providing a unified, auditable platform for regulatory compliance.